COVID-19: A Perspective from Clinical Neurology and Neuroscience

Neuroscientist. 2020 Oct-Dec;26(5-6):387-391. doi: 10.1177/1073858420946749. Epub 2020 Jul 25.

Abstract

Despite the increasing large population of COVID-19+ infected patients, knowledge of the disease remains limited. Understanding the effects and long-term implications of COVID-19 will be paramount to implementing the right public health measures and developing future preventive and effective treatments. In this article, we discuss currently available information with COVID-19-related neurological complications, possible routes of virus infection into the central nervous system, and hypothesis about virus-induced cytokine storm syndrome, long-term outcomes, as well as ongoing clinical studies of novel therapies and biomarkers for COVID-19. Understanding the effects of COVID-19 on neurological systems is crucial for properly diagnosing and caring for the disease. We need to be prepared that COVID-19 could cause long-lasting debilitations after the infection has cleared. Investigating long-term effects of the disease will yield insight for providing comprehensive care to the survivors. Understanding these risks will also lead to better treatments as well as inform policies to create a system capable of caring for those affected by COVID-19 long after the pandemic has subsided.

Keywords: COVID-19; biomarkers; long-term effects; neurological symptoms; novel therapies.

Publication types

  • Review

MeSH terms

  • Betacoronavirus
  • Biomarkers / metabolism
  • COVID-19
  • Central Nervous System Diseases / epidemiology*
  • Comorbidity
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology*
  • Humans
  • Immune System Diseases / epidemiology*
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2

Substances

  • Biomarkers